Singapore Pharma Report


This report offers companies, investors, policymakers, and stakeholders crucial insight into Singapore; a nation that has had to carve out its own niche as a global trade hub and gateway to the Asia-Pacific region to compete globally since declaring independence in 1965. In terms of healthcare and life sciences, the island now serves as a regional hub for myriad multinationals, stands at the forefront of cutting-edge scientific research and development, and is globally renowned in several important levels of the pharmaceutical supply chain.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on Singapore’s healthcare and pharma sectors.